These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 18339595

  • 1. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 2. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [Abstract] [Full Text] [Related]

  • 3. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 4. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 5. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 7. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G.
    Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
    [Abstract] [Full Text] [Related]

  • 8. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
    Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, Lee SD.
    Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
    [Abstract] [Full Text] [Related]

  • 9. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS.
    Scand J Gastroenterol; 2009 Sep; 44(3):346-57. PubMed ID: 18991165
    [Abstract] [Full Text] [Related]

  • 10. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J.
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [Abstract] [Full Text] [Related]

  • 11. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 12. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 13. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S, Gane EJ, McCall JL, Plank LD.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [Abstract] [Full Text] [Related]

  • 14. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

  • 15. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI, Lin HC, Huang YH, Wu JC, Chiang JH, Lee PC, Lee SD.
    Cancer; 2006 Jul 01; 107(1):141-8. PubMed ID: 16708358
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ, Chen HA, Lu MQ, Chen GH.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2065-9. PubMed ID: 19080277
    [Abstract] [Full Text] [Related]

  • 17. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
    Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, Lee FY, Lee SD.
    Liver Int; 2007 May 20; 27(4):498-506. PubMed ID: 17403190
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    Korean J Hepatol; 2009 Sep 20; 15(3):350-6. PubMed ID: 19783884
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee JY, Lee SD.
    Dig Liver Dis; 2010 Feb 20; 42(2):137-42. PubMed ID: 19595648
    [Abstract] [Full Text] [Related]

  • 20. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.
    Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL.
    Liver Transpl; 2007 Sep 20; 13(9):1228-35. PubMed ID: 17763399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.